Neo-adjuvant chemo-(immuno-) therapy of advanced head and neck squamous cell carcinoma (HNSCC): A multicenter phase III randomized study comparing cisplatin (CDDP) + 5-FU with CDDP + 5-FU + recombinant interleukin 2 (rIL 2): Preliminary results
G. Mantovani; M. Airoldi; A. Bianchi; M. Ghiani; G. Succu; D. Massa; L. Curreli; B. Lampis; P. Lai; G. Cadeddu; C. Bumma
- 作者G. Mantovani; M. Airoldi; A. Bianchi; M. Ghiani; G. Succu; D. Massa; L. Curreli; B. Lampis; P. Lai; G. Cadeddu; C. Bumma
- 卷第33卷
- 印刷ISSN0959-8049
- 文件大小135.15KB
- 发表时间1997
- DOI10.1016/s0959-8049(97)89404-x